CHOLESTECH LDX ASPARTATE AMINOTRANSFERASE (AST)— 510(k) K032027

Substantially Equivalent

Cholestech Corp.

FDA 510(k) clearance K032027 for CHOLESTECH LDX ASPARTATE AMINOTRANSFERASE (AST), Substantially Equivalent on 2003-09-05. Applicant: Cholestech Corp..

Clearance details

Applicant: Cholestech Corp.
Product code: Code CIS
Advisory panel: Clinical Chemistry
Date received: 2003-07-01
Decision date: 2003-09-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hayward, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.